newsletter
The Altascientist
THE ALTASCIENTIST JANUARY 2019 ISSUE NO. 7
Effective pharmaceutical therapies — Understanding the intrinsic and extrinsic factors that alter exposure to limit adverse effects and maximize treatment response
SELECT A CATEGORY BELOW
NEWSLETTER
-
Newsletter
April 2018
Get the Scoop – A case study on cannabis, our latest assay list, and much more!
Get the Scoop – A case study on cannabis, our latest assay list, and much more!
-
Newsletter
January 2018
GET THE SCOOP — Up Close and Personal with our CEO and 5 Ways to Save Money on Outsourcing
GET THE SCOOP — Up Close and Personal with our CEO and 5 Ways to Save Money on Outsourcing
-
Newsletter
June 2017
Guideline on Equivalence Studies, Metabolic Disorders and your chance to ask our experts questions directly about hot topics like Biotherapeutics and Therapeutic Equivalence.
Guideline on Equivalence Studies, Metabolic Disorders and your chance to ask our experts questions directly about hot topics like Biotherapeutics and Therapeutic Equivalence.
-
Newsletter
February 2017
Learn about our cannabis study, biosimilars, our diabetes case studies, and so much more!
Learn about our cannabis study, biosimilars, our diabetes case studies, and so much more!
-
Newsletter
December 2016
On December 2nd, the FDA published a guidance intended to assist applicants in preparing the clinical pharmacology section of prescription drug labeling.
On December 2nd, the FDA published a guidance intended to assist applicants in preparing the clinical pharmacology section of prescription drug labeling.
-
Newsletter
November 2016
On November 10th, the European Medicines Agency followed through on plans to update its guidance on first-in-human clinical trials.
On November 10th, the European Medicines Agency followed through on plans to update its guidance on first-in-human clinical trials.
-
Newsletter
October 2016
For everything you need to know about our alternative solution to assess transdermal patch adhesion, our interactive timeline planning tool, and so much more!
For everything you need to know about our alternative solution to assess transdermal patch adhesion, our interactive timeline planning tool, and so much more!